Global Imatinib Mesylate Sales Market Report 2016

December 2016 | 103 pages | ID: G784EB821FFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Imatinib Mesylate

Revenue, means the sales value of Imatinib Mesylate

This report studies sales (consumption) of Imatinib Mesylate in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Sanofi SA (France)
• Wyeth (US)
• GlaxoSmithKline Plc (UK)
• Abbott Laboratories (USA)
• Pfizer Inc. (USA)
• Eli Lilly and Company (US)
• Merck & Co., Inc. (US)
• Warner Chilcott plc (Ireland)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Imatinib Mesylate in these regions, from 2011 to 2021 (forecast), like

• United States
• China
• Europe
• Japan

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Imatinib Mesylate in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Imatinib Mesylate Sales Market Report 2016

1 IMATINIB MESYLATE OVERVIEW

1.1 Product Overview and Scope of Imatinib Mesylate
1.2 Classification of Imatinib Mesylate
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Imatinib Mesylate
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Imatinib Mesylate Market by Regions
  1.4.1 United States Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Imatinib Mesylate (2011-2021)
  1.5.1 Global Imatinib Mesylate Sales and Growth Rate (2011-2021)
  1.5.2 Global Imatinib Mesylate Revenue and Growth Rate (2011-2021)

2 GLOBAL IMATINIB MESYLATE COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Imatinib Mesylate Market Competition by Manufacturers
  2.1.1 Global Imatinib Mesylate Sales and Market Share of Key Manufacturers (2011-2016)
  2.1.2 Global Imatinib Mesylate Revenue and Share by Manufacturers (2011-2016)
2.2 Global Imatinib Mesylate (Volume and Value) by Type
  2.2.1 Global Imatinib Mesylate Sales and Market Share by Type (2011-2016)
  2.2.2 Global Imatinib Mesylate Revenue and Market Share by Type (2011-2016)
2.3 Global Imatinib Mesylate (Volume and Value) by Regions
  2.3.1 Global Imatinib Mesylate Sales and Market Share by Regions (2011-2016)
  2.3.2 Global Imatinib Mesylate Revenue and Market Share by Regions (2011-2016)
2.4 Global Imatinib Mesylate (Volume) by Application

3 UNITED STATES IMATINIB MESYLATE (VOLUME, VALUE AND SALES PRICE)

3.1 United States Imatinib Mesylate Sales and Value (2011-2016)
  3.1.1 United States Imatinib Mesylate Sales and Growth Rate (2011-2016)
  3.1.2 United States Imatinib Mesylate Revenue and Growth Rate (2011-2016)
  3.1.3 United States Imatinib Mesylate Sales Price Trend (2011-2016)
3.2 United States Imatinib Mesylate Sales and Market Share by Manufacturers
3.3 United States Imatinib Mesylate Sales and Market Share by Type
3.4 United States Imatinib Mesylate Sales and Market Share by Application

4 CHINA IMATINIB MESYLATE (VOLUME, VALUE AND SALES PRICE)

4.1 China Imatinib Mesylate Sales and Value (2011-2016)
  4.1.1 China Imatinib Mesylate Sales and Growth Rate (2011-2016)
  4.1.2 China Imatinib Mesylate Revenue and Growth Rate (2011-2016)
  4.1.3 China Imatinib Mesylate Sales Price Trend (2011-2016)
4.2 China Imatinib Mesylate Sales and Market Share by Manufacturers
4.3 China Imatinib Mesylate Sales and Market Share by Type
4.4 China Imatinib Mesylate Sales and Market Share by Application

5 EUROPE IMATINIB MESYLATE (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Imatinib Mesylate Sales and Value (2011-2016)
  5.1.1 Europe Imatinib Mesylate Sales and Growth Rate (2011-2016)
  5.1.2 Europe Imatinib Mesylate Revenue and Growth Rate (2011-2016)
  5.1.3 Europe Imatinib Mesylate Sales Price Trend (2011-2016)
5.2 Europe Imatinib Mesylate Sales and Market Share by Manufacturers
5.3 Europe Imatinib Mesylate Sales and Market Share by Type
5.4 Europe Imatinib Mesylate Sales and Market Share by Application

6 JAPAN IMATINIB MESYLATE (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Imatinib Mesylate Sales and Value (2011-2016)
  6.1.1 Japan Imatinib Mesylate Sales and Growth Rate (2011-2016)
  6.1.2 Japan Imatinib Mesylate Revenue and Growth Rate (2011-2016)
  6.1.3 Japan Imatinib Mesylate Sales Price Trend (2011-2016)
6.2 Japan Imatinib Mesylate Sales and Market Share by Manufacturers
6.3 Japan Imatinib Mesylate Sales and Market Share by Type
6.4 Japan Imatinib Mesylate Sales and Market Share by Application

7 GLOBAL IMATINIB MESYLATE MANUFACTURERS ANALYSIS

7.1 Sanofi SA (France)
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Imatinib Mesylate Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Sanofi SA (France) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.1.4 Main Business/Business Overview
7.2 Wyeth (US)
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 103 Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Wyeth (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.2.4 Main Business/Business Overview
7.3 GlaxoSmithKline Plc (UK)
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 125 Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 GlaxoSmithKline Plc (UK) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.3.4 Main Business/Business Overview
7.4 Abbott Laboratories (USA)
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Dec Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Abbott Laboratories (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer Inc. (USA)
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Inc. (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.5.4 Main Business/Business Overview
7.6 Eli Lilly and Company (US)
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Million USD Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Eli Lilly and Company (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.6.4 Main Business/Business Overview
7.7 Merck & Co., Inc. (US)
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Pharma & Healthcare Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Merck & Co., Inc. (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.7.4 Main Business/Business Overview
7.8 Warner Chilcott plc (Ireland)
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Warner Chilcott plc (Ireland) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
  7.8.4 Main Business/Business Overview

8 IMATINIB MESYLATE MAUFACTURING COST ANALYSIS

8.1 Imatinib Mesylate Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Process Analysis of Imatinib Mesylate

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Imatinib Mesylate Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL IMATINIB MESYLATE MARKET FORECAST (2016-2021)

12.1 Global Imatinib Mesylate Sales, Revenue Forecast (2016-2021)
12.2 Global Imatinib Mesylate Sales Forecast by Regions (2016-2021)
12.3 Global Imatinib Mesylate Sales Forecast by Type (2016-2021)
12.4 Global Imatinib Mesylate Sales Forecast by Application (2016-2021)

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Imatinib Mesylate
Table Classification of Imatinib Mesylate
Figure Global Sales Market Share of Imatinib Mesylate by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Imatinib Mesylate
Figure Global Sales Market Share of Imatinib Mesylate by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Figure China Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Figure Europe Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Figure Japan Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Figure Global Imatinib Mesylate Sales and Growth Rate (2011-2021)
Figure Global Imatinib Mesylate Revenue and Growth Rate (2011-2021)
Table Global Imatinib Mesylate Sales of Key Manufacturers (2011-2016)
Table Global Imatinib Mesylate Sales Share by Manufacturers (2011-2016)
Figure 2015 Imatinib Mesylate Sales Share by Manufacturers
Figure 2016 Imatinib Mesylate Sales Share by Manufacturers
Table Global Imatinib Mesylate Revenue by Manufacturers (2011-2016)
Table Global Imatinib Mesylate Revenue Share by Manufacturers (2011-2016)
Table 2015 Global Imatinib Mesylate Revenue Share by Manufacturers
Table 2016 Global Imatinib Mesylate Revenue Share by Manufacturers
Table Global Imatinib Mesylate Sales and Market Share by Type (2011-2016)
Table Global Imatinib Mesylate Sales Share by Type (2011-2016)
Figure Sales Market Share of Imatinib Mesylate by Type (2011-2016)
Figure Global Imatinib Mesylate Sales Growth Rate by Type (2011-2016)
Table Global Imatinib Mesylate Revenue and Market Share by Type (2011-2016)
Table Global Imatinib Mesylate Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Imatinib Mesylate by Type (2011-2016)
Figure Global Imatinib Mesylate Revenue Growth Rate by Type (2011-2016)
Table Global Imatinib Mesylate Sales and Market Share by Regions (2011-2016)
Table Global Imatinib Mesylate Sales Share by Regions (2011-2016)
Figure Sales Market Share of Imatinib Mesylate by Regions (2011-2016)
Figure Global Imatinib Mesylate Sales Growth Rate by Regions (2011-2016)
Table Global Imatinib Mesylate Revenue and Market Share by Regions (2011-2016)
Table Global Imatinib Mesylate Revenue Share by Regions (2011-2016)
Figure Revenue Market Share of Imatinib Mesylate by Regions (2011-2016)
Figure Global Imatinib Mesylate Revenue Growth Rate by Regions (2011-2016)
Table Global Imatinib Mesylate Sales and Market Share by Application (2011-2016)
Table Global Imatinib Mesylate Sales Share by Application (2011-2016)
Figure Sales Market Share of Imatinib Mesylate by Application (2011-2016)
Figure Global Imatinib Mesylate Sales Growth Rate by Application (2011-2016)
Figure United States Imatinib Mesylate Sales and Growth Rate (2011-2016)
Figure United States Imatinib Mesylate Revenue and Growth Rate (2011-2016)
Figure United States Imatinib Mesylate Sales Price Trend (2011-2016)
Table United States Imatinib Mesylate Sales by Manufacturers (2011-2016)
Table United States Imatinib Mesylate Market Share by Manufacturers (2011-2016)
Table United States Imatinib Mesylate Sales by Type (2011-2016)
Table United States Imatinib Mesylate Market Share by Type (2011-2016)
Table United States Imatinib Mesylate Sales by Application (2011-2016)
Table United States Imatinib Mesylate Market Share by Application (2011-2016)
Figure China Imatinib Mesylate Sales and Growth Rate (2011-2016)
Figure China Imatinib Mesylate Revenue and Growth Rate (2011-2016)
Figure China Imatinib Mesylate Sales Price Trend (2011-2016)
Table China Imatinib Mesylate Sales by Manufacturers (2011-2016)
Table China Imatinib Mesylate Market Share by Manufacturers (2011-2016)
Table China Imatinib Mesylate Sales by Type (2011-2016)
Table China Imatinib Mesylate Market Share by Type (2011-2016)
Table China Imatinib Mesylate Sales by Application (2011-2016)
Table China Imatinib Mesylate Market Share by Application (2011-2016)
Figure Europe Imatinib Mesylate Sales and Growth Rate (2011-2016)
Figure Europe Imatinib Mesylate Revenue and Growth Rate (2011-2016)
Figure Europe Imatinib Mesylate Sales Price Trend (2011-2016)
Table Europe Imatinib Mesylate Sales by Manufacturers (2011-2016)
Table Europe Imatinib Mesylate Market Share by Manufacturers (2011-2016)
Table Europe Imatinib Mesylate Sales by Type (2011-2016)
Table Europe Imatinib Mesylate Market Share by Type (2011-2016)
Table Europe Imatinib Mesylate Sales by Application (2011-2016)
Table Europe Imatinib Mesylate Market Share by Application (2011-2016)
Figure Japan Imatinib Mesylate Sales and Growth Rate (2011-2016)
Figure Japan Imatinib Mesylate Revenue and Growth Rate (2011-2016)
Figure Japan Imatinib Mesylate Sales Price Trend (2011-2016)
Table Japan Imatinib Mesylate Sales by Manufacturers (2011-2016)
Table Japan Imatinib Mesylate Market Share by Manufacturers (2011-2016)
Table Japan Imatinib Mesylate Sales by Type (2011-2016)
Table Japan Imatinib Mesylate Market Share by Type (2011-2016)
Table Japan Imatinib Mesylate Sales by Application (2011-2016)
Table Japan Imatinib Mesylate Market Share by Application (2011-2016)
Table Sanofi SA (France) Basic Information List
Table Sanofi SA (France) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi SA (France) Imatinib Mesylate Global Market Share (2011-2016)
Table Wyeth (US) Basic Information List
Table Wyeth (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Wyeth (US) Imatinib Mesylate Global Market Share (2011-2016)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc (UK) Imatinib Mesylate Global Market Share (2011-2016)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (USA) Imatinib Mesylate Global Market Share (2011-2016)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Inc. (USA) Imatinib Mesylate Global Market Share (2011-2016)
Table Eli Lilly and Company (US) Basic Information List
Table Eli Lilly and Company (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly and Company (US) Imatinib Mesylate Global Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information List
Table Merck & Co., Inc. (US) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Imatinib Mesylate Global Market Share (2011-2016)
Table Warner Chilcott plc (Ireland) Basic Information List
Table Warner Chilcott plc (Ireland) Imatinib Mesylate Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Warner Chilcott plc (Ireland) Imatinib Mesylate Global Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imatinib Mesylate
Figure Manufacturing Process Analysis of Imatinib Mesylate
Figure Imatinib Mesylate Industrial Chain Analysis
Table Raw Materials Sources of Imatinib Mesylate Major Manufacturers in 2015
Table Major Buyers of Imatinib Mesylate
Table Distributors/Traders List
Figure Global Imatinib Mesylate Sales and Growth Rate Forecast (2016-2021)
Figure Global Imatinib Mesylate Revenue and Growth Rate Forecast (2016-2021)
Table Global Imatinib Mesylate Sales Forecast by Regions (2016-2021)
Table Global Imatinib Mesylate Sales Forecast by Type (2016-2021)
Table Global Imatinib Mesylate Sales Forecast by Application (2016-2021)